Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Gordon

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|April 15, 1988
Carcinogenicity of deuterium-labeled 1,2-dimethylhydrazine in miceV S Turusov, N S Lanko, Y D Parfenov, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1985
Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediatesA W Rettenmeier, K S Prickett, W P Gordon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1986
Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acidA W Rettenmeier, W P Gordon, K S Prickett, et al.
Biomedical & Environmental Mass Spectrometry|March 1, 1989
Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniquesA W Rettenmeier, W N Howald, R H Levy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1979
Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometryR K Lynn, J E Bauer, W P Gordon, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|April 15, 1988
Carcinogenicity of deuterium-labeled 1,2-dimethylhydrazine in miceV S Turusov, N S Lanko, Y D Parfenov, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1985
Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediatesA W Rettenmeier, K S Prickett, W P Gordon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1986
Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acidA W Rettenmeier, W P Gordon, K S Prickett, et al.
Biomedical & Environmental Mass Spectrometry|March 1, 1989
Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniquesA W Rettenmeier, W N Howald, R H Levy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1979
Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometryR K Lynn, J E Bauer, W P Gordon, et al.
Pageof 4